Mark Massaro
Stock Analyst at BTIG
(3.74)
# 511
Out of 5,182 analysts
162
Total ratings
42.48%
Success rate
10.29%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOPH SOPHiA GENETICS | Maintains: Buy | $7 → $8 | $4.86 | +64.61% | 4 | Apr 15, 2026 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $2.5 | $1.06 | +135.85% | 5 | Mar 30, 2026 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $9 → $5 | $7.82 | -36.06% | 8 | Mar 12, 2026 | |
| XGN Exagen | Maintains: Buy | $10 → $9 | $2.74 | +228.47% | 7 | Mar 10, 2026 | |
| BLLN BillionToOne | Maintains: Buy | $160 → $140 | $81.76 | +71.23% | 3 | Mar 5, 2026 | |
| CAI Caris Life Sciences | Maintains: Buy | $45 → $38 | $19.93 | +90.67% | 1 | Feb 27, 2026 | |
| CDNA CareDx | Maintains: Buy | $25 → $26 | $21.85 | +18.99% | 6 | Feb 26, 2026 | |
| TEM Tempus AI | Maintains: Buy | $105 → $90 | $52.68 | +70.84% | 7 | Feb 25, 2026 | |
| WGS GeneDx Holdings | Maintains: Buy | $200 → $170 | $66.17 | +156.91% | 8 | Feb 24, 2026 | |
| GH Guardant Health | Maintains: Buy | $140 → $145 | $88.50 | +63.84% | 8 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $13 | $5.96 | +118.12% | 5 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $14.21 | +54.82% | 8 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $830 → $800 | $574.95 | +39.14% | 3 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.04 | +243.14% | 10 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $50 | $24.98 | +100.16% | 6 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $230 → $260 | $204.39 | +27.21% | 16 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $160 | $117.87 | +35.74% | 4 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.87 | - | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.23 | - | 8 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $8.61 | +143.90% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.14 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.98 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $128.52 | +133.43% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $196.63 | -43.04% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $263.43 | -37.36% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $12.29 | +550.94% | 9 | Sep 10, 2018 |
SOPHiA GENETICS
Apr 15, 2026
Maintains: Buy
Price Target: $7 → $8
Current: $4.86
Upside: +64.61%
Lucid Diagnostics
Mar 30, 2026
Reiterates: Buy
Price Target: $2.5
Current: $1.06
Upside: +135.85%
Ginkgo Bioworks Holdings
Mar 12, 2026
Maintains: Sell
Price Target: $9 → $5
Current: $7.82
Upside: -36.06%
Exagen
Mar 10, 2026
Maintains: Buy
Price Target: $10 → $9
Current: $2.74
Upside: +228.47%
BillionToOne
Mar 5, 2026
Maintains: Buy
Price Target: $160 → $140
Current: $81.76
Upside: +71.23%
Caris Life Sciences
Feb 27, 2026
Maintains: Buy
Price Target: $45 → $38
Current: $19.93
Upside: +90.67%
CareDx
Feb 26, 2026
Maintains: Buy
Price Target: $25 → $26
Current: $21.85
Upside: +18.99%
Tempus AI
Feb 25, 2026
Maintains: Buy
Price Target: $105 → $90
Current: $52.68
Upside: +70.84%
GeneDx Holdings
Feb 24, 2026
Maintains: Buy
Price Target: $200 → $170
Current: $66.17
Upside: +156.91%
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $140 → $145
Current: $88.50
Upside: +63.84%
Feb 11, 2026
Maintains: Buy
Price Target: $12 → $13
Current: $5.96
Upside: +118.12%
Feb 6, 2026
Maintains: Buy
Price Target: $21 → $22
Current: $14.21
Upside: +54.82%
Feb 3, 2026
Maintains: Buy
Price Target: $830 → $800
Current: $574.95
Upside: +39.14%
Dec 23, 2025
Reiterates: Buy
Price Target: $7
Current: $2.04
Upside: +243.14%
Dec 12, 2025
Maintains: Buy
Price Target: $38 → $50
Current: $24.98
Upside: +100.16%
Dec 5, 2025
Maintains: Buy
Price Target: $230 → $260
Current: $204.39
Upside: +27.21%
Dec 3, 2025
Reiterates: Buy
Price Target: $160
Current: $117.87
Upside: +35.74%
Aug 11, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.87
Upside: -
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.23
Upside: -
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $8.61
Upside: +143.90%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.14
Upside: -
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.98
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $128.52
Upside: +133.43%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $196.63
Upside: -43.04%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $263.43
Upside: -37.36%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $12.29
Upside: +550.94%